Free Trial
NYSE:ENFN

Enfusion Q1 2025 Earnings Report

Enfusion logo
$10.85 +0.05 (+0.45%)
Closing price 04/17/2025
Extended Trading
$10.85 0.00 (0.00%)
As of 04/17/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enfusion EPS Results

Actual EPS
N/A
Consensus EPS
$0.06
Beat/Miss
N/A
One Year Ago EPS
N/A

Enfusion Revenue Results

Actual Revenue
N/A
Expected Revenue
$55.08 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Enfusion Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Enfusion Earnings Headlines

Clearwater Analytics reinstated with an Overweight at JPMorgan
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Enfusion Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Enfusion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enfusion and other key companies, straight to your email.

About Enfusion

Enfusion (NYSE:ENFN) provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

View Enfusion Profile

More Earnings Resources from MarketBeat